# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeut...
The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-...
Truist Securities analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target ...
Leerink Partners maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and raises the price target from $106 to $127.
CMS proposes new Medicare payment rates for 2025, addressing diagnostic radiopharmaceutical costs. The proposed rule includes s...